Pinned post
(4) Nextgen IL2s w reduced binding to CD25, induce less Treg proliferation and have had encouraging results in trials.
Our third-gen anti-CTLA-4 with limited ability to block CTLA-4 induces less Treg proliferation, has enhanced anti-tumor efficacy but reduced toxicity in models
Our third-gen anti-CTLA-4 with limited ability to block CTLA-4 induces less Treg proliferation, has enhanced anti-tumor efficacy but reduced toxicity in models